Sonoma Pharmaceuticals (SNOA) Gains on FDA Clearance

Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) shares rose 1.7% to $7.20 after the company reported the FDA clearance of Loyon Skin Descaler. Share volume was 270,000 an all-day average of 41,000